Latest total liabilities for ENTXW: $12M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Entera Bio Ltd - Warrants (02/07/2023) (ENTXW) currently reports a total liabilities of $12M as of June 2026. That compares with $2.4M in the prior-year period — up 406.6% year over year. Use the charts on this page to explore Entera Bio Ltd - Warrants (02/07/2023)'s total liabilities history and peer comparisons.
Entera Bio Ltd - Warrants (02/07/2023)'s total liabilities increased from $2.4M to $12M — a 406.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Entera Bio Ltd - Warrants (02/07/2023) reported $12M in total liabilities as of June 2026. That compares with $2.4M in the prior-year period — up 406.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Entera Bio Ltd - Warrants (02/07/2023), and consider following ENTXW for alerts when major investors trade the stock.
Entera Bio Ltd - Warrants (02/07/2023) is classified in the Healthcare sector. On total liabilities, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENTXW with unrelated industries.